Sederma invests in plant cell cultures
Acquires Europe’s first commercialised 600 litre bench wave system bioreactor
To help achieve this, Sederma has acquired a 600 litre bench wave system bioreactor – the first to be commercialised in Europe.
The company is also in the process of developing the knowledge to offer advanced services and solutions in fields including the optimisation of culture conditions, selection and production of metabolites, analytical methods, generation of a callus bank and cryopreservation of cell lines.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Why ginger could be the secret to tackling undereye dark circles
Read moreSederma's Ameyezing 4.0 counteracts both vascular and hyperpigmented dark circles, as Pascaline Criton, Marketing Communications Manager at Sederma, explains
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.